Stocktoria
Raia Drogasil S.A. RADL3.SA
BR · B3 (Brasil Bolsa) · XBSP · stock · Healthcare · website
Raia Drogasil S.A. statistics & valuation
Market cap$29.4B
P / E22.7×
P / S0.7×
P / B4.0×
P / FCF276.0×
Net margin2.9%
Return on equity17.7%
FCF margin0.2%
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Raia Drogasil S.A. trades at about 21.5× earnings — below its 10-year norm (10-year range 29.1×–39.6×, median 39.1×).
21.5×
39.6×
Shaded band = 10-year range (29.1×–39.6×); dot = today's 21.5×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 29.3% | 29.7% | 30.0% | 30.3% |
| Operating margin | 6.0% | 6.1% | 5.7% | 6.4% |
| Net margin | 2.9% | 3.1% | 3.1% | 3.4% |
| FCF margin | 0.2% | 1.6% | -1.0% | -1.2% |
| Return on assets | 5.2% | 5.4% | 5.3% | 5.8% |
| Return on equity | 17.7% | 18.7% | 17.7% | 18.7% |
| Debt / equity | 0.46× | 0.41× | 0.42× | 0.40× |
| Current ratio | 1.46 | 1.38 | 1.43 | 1.50 |
Source: company filings via Yahoo Finance · BR · as of 2025-12-31. Figures in BRL; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.